Evidence map›Paper›PMID 37259518›Full record

ArticleJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2024

Attitude of healthcare professionals toward the use of complementary and alternative medication during anti-cancer therapy.

O M Sont, M D Rombouts, M Crul

Registry-linked trialAbstract read
In one paragraph

Article in Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07745205 (HEALTHS - Holistic Evaluation of Approaches to Long-term Health and Survivorship), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07745205 naactive not recruitingnot on this mapstarted 2026, after this paper: background citation

HEALTHS - Holistic Evaluation of Approaches to Long-term Health and Survivorship (Focus Phytotherapy) A Single-center, Minimal-risk, Two-phase Study Including a Quantitative Observational Survey and an Interventional Mixed-methods Component With Focus Group Sessions.

TypeinterventionalSponsorJules Bordet InstituteRan2026 to 2027Enrolled500ConditionsAdult Cancer Survivors, Adult Cancer PatientsArmsInterventional mixed-methods evaluation of cancer patient's behaviour regarding CAMs (focus groups), Quantitative evaluation of cancer patient's use of CAM's
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

O M SontDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
M D RomboutsDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
M CrulDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.ORCID 0000-0002-4929-2388

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePatients with cancer often use complementary and alternative medication (CAM). This research aims to study the current attitude of healthcare professionals toward the use of CAM to improve current care.

methodsA questionnaire on both the current practice and opinions about CAM use was sent to healthcare professionals in Amsterdam UMC, who work for the department of hematology or oncology. Oncologists, hematologists, residents, (specialized) nurses, dieticians, (hospital)pharmacists, and pharmacy technicians were asked to participate in this study.

resultsAmong eligible healthcare professionals, 77 responded to the questionnaire (34%). Overall, 87% of healthcare professionals indicate it is important to be aware of their patient's CAM use, and all find the potential of drug-herb interactions important. However, more than half of the healthcare professionals inquire about the patient's CAM use infrequently. In addition, only 15% of the healthcare professionals stated they had sufficient knowledge of CAM to advise patients on their use of CAM.

conclusionsHealthcare professionals are aware of the potential risks of CAM use in combination with anti-cancer treatment. However, CAM use is not yet discussed with every patient. This may be due to healthcare professionals' lack of knowledge about CAM.

Indexed as

Attitude of Health PersonnelComplementary TherapiesHealth PersonnelNeoplasmsAdultAntineoplastic AgentsFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedSurveys and QuestionnairesAntineoplastic AgentsCAMComplementary and alternative medicinehealthcare professionalspatient care

Identifiers

PMID37259518
PMCPMC11118789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.